Cargando…
The Impact of COVID-19 Infection in Cancer 2020–2021
This Editorial summarizes the findings of the articles submitted in 2020 and 2021 to the Special Issue “The Impact of COVID-19 in Cancer”.
Autores principales: | D’Orazi, Gabriella, Cirone, Mara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738891/ https://www.ncbi.nlm.nih.gov/pubmed/36497376 http://dx.doi.org/10.3390/cancers14235895 |
Ejemplares similares
-
The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study
por: Garufi, Alessia, et al.
Publicado: (2022) -
Interconnected Adaptive Responses: A Way Out for Cancer Cells to Avoid Cellular Demise
por: D’Orazi, Gabriella, et al.
Publicado: (2022) -
NRF2 in Cancer: Cross-Talk with Oncogenic Pathways and Involvement in Gammaherpesvirus-Driven Carcinogenesis
por: Cirone, Mara, et al.
Publicado: (2022) -
Mutant p53 and Cellular Stress Pathways: A Criminal Alliance That Promotes Cancer Progression
por: D’Orazi, Gabriella, et al.
Publicado: (2019) -
HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases
por: Garufi, Alessia, et al.
Publicado: (2023)